Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 570

1.

Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.

Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, Taylor R, Watkin P, Fonseca S, Davis A, Hind S.

Health Technol Assess. 2007 Aug;11(32):1-168, iii-iv. Review.

2.

Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.

Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I.

Health Technol Assess. 2007 Oct;11(42):1-294.

3.

A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes.

Fortnum H, Ukoumunne OC, Hyde C, Taylor RS, Ozolins M, Errington S, Zhelev Z, Pritchard C, Benton C, Moody J, Cocking L, Watson J, Roberts S.

Health Technol Assess. 2016 May;20(36):1-178. doi: 10.3310/hta20360.

4.

United Kingdom school-entry hearing screening: current practice.

Bristow K, Fortnum H, Fonseca S, Bamford J.

Arch Dis Child. 2008 Mar;93(3):232-5. Epub 2007 Nov 26.

PMID:
18039746
5.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

6.
7.

Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation.

Colquitt JL, Jones J, Harris P, Loveman E, Bird A, Clegg AJ, Baguley DM, Proops DW, Mitchell TE, Sheehan PZ, Welch K.

Health Technol Assess. 2011 Jul;15(26):1-200, iii-iv. doi: 10.3310/hta15260. Review.

8.

Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.

Sharma P, Boyers D, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Kilonzo M, McNamee P, Mowatt G.

Health Technol Assess. 2012;16(17):1-266. doi: 10.3310/hta16170. Review.

9.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

10.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

11.

The cost-effectiveness of screening for oral cancer in primary care.

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.

Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.

12.

Projected cost-effectiveness of statewide universal newborn hearing screening.

Keren R, Helfand M, Homer C, McPhillips H, Lieu TA.

Pediatrics. 2002 Nov;110(5):855-64.

PMID:
12415021
13.

The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.

Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A.

Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190. Review.

14.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

15.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

16.

A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment.

Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S.

Health Technol Assess. 1997;1(10):i-iv, 1-176. Review.

17.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

18.

Universal newborn hearing screening: summary of evidence.

Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand M.

JAMA. 2001 Oct 24-31;286(16):2000-10. Review.

PMID:
11667937
19.

Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.

McCormack K, Wake B, Perez J, Fraser C, Cook J, McIntosh E, Vale L, Grant A.

Health Technol Assess. 2005 Apr;9(14):1-203, iii-iv. Review.

20.

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.

Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.

Supplemental Content

Support Center